Triangle Urological Group is categorized under Urologists in Grove City, PA and active since 2009.
Triangle Urological Group was established in 2009, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Urologists business, which does work in the B2C market, and is classified as a Urologists, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact John Lyne at the company’s single location by writing to 432 Hillcrest Avenue # 1, Grove City, Pennsylvania PA 16127 or by phoning (724) 264-4190. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Triangle Urological Group |
| Contact Person: | John Lyne |
| Address: | 432 Hillcrest Avenue # 1, Grove City, Pennsylvania 16127 |
| Phone Number: | (724) 264-4190 |
| Website Address: | triangleurology.com |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2009 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Urologists |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Triangle Urological Group was started in 2009 to provide professional Urologists under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact John Lyne for inquiries that concern Triangle Urological Group by calling the company number (724) 264-4190, as your correspondence is most welcome. Additionally, the physical location of the single location of Triangle Urological Group can be found at the coordinates 41.16688,-80.08616 as well as the street address 432 Hillcrest Avenue # 1 in Grove City, Pennsylvania 16127.
For its online presence, you may visit Triangle Urological Group’s website at triangleurology.com and engage with its social media outlets through on Twitter and on Facebook.